NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,510 | +0.9% | 113 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $11,403 | +9.7% | 113 | 0.0% | 0.01% | +8.3% |
| Q1 2023 | $10,396 | +103860.0% | 113 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $10 | -99.9% | 113 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $9,000 | -50.0% | 113 | -46.7% | 0.01% | -42.9% |
| Q2 2022 | $18,000 | -5.3% | 212 | 0.0% | 0.02% | +16.7% |
| Q1 2022 | $19,000 | -99.9% | 212 | +7.6% | 0.02% | +28.6% |
| Q4 2021 | $17,232,000 | – | 197 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |